nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—Histamine H1 Receptor Antagonists—Diphenhydramine—atopic dermatitis	0.577	1	CiPCiCtD
Azelastine—Cloperastine—Dimenhydrinate—atopic dermatitis	0.0848	0.678	CrCrCtD
Azelastine—Cloperastine—Diphenhydramine—atopic dermatitis	0.0403	0.322	CrCrCtD
Azelastine—HRH1—Dimenhydrinate—atopic dermatitis	0.0224	0.0966	CbGbCtD
Azelastine—KCNH2—Loratadine—atopic dermatitis	0.0186	0.08	CbGbCtD
Azelastine—CYP2C8—Mometasone—atopic dermatitis	0.0119	0.0514	CbGbCtD
Azelastine—HRH1—Loratadine—atopic dermatitis	0.011	0.0472	CbGbCtD
Azelastine—HRH1—Diphenhydramine—atopic dermatitis	0.011	0.0472	CbGbCtD
Azelastine—CYP3A5—Tacrolimus—atopic dermatitis	0.00974	0.042	CbGbCtD
Azelastine—CYP2B6—Diphenhydramine—atopic dermatitis	0.00905	0.039	CbGbCtD
Azelastine—CYP2A6—Prednisolone—atopic dermatitis	0.00816	0.0351	CbGbCtD
Azelastine—CYP2C8—Loratadine—atopic dermatitis	0.00686	0.0295	CbGbCtD
Azelastine—CYP3A4—Pimecrolimus—atopic dermatitis	0.00639	0.0275	CbGbCtD
Azelastine—ABCB1—Tacrolimus—atopic dermatitis	0.00634	0.0273	CbGbCtD
Azelastine—CYP2C19—Loratadine—atopic dermatitis	0.00575	0.0248	CbGbCtD
Azelastine—CYP2C19—Diphenhydramine—atopic dermatitis	0.00575	0.0248	CbGbCtD
Azelastine—CYP1A2—Diphenhydramine—atopic dermatitis	0.00531	0.0229	CbGbCtD
Azelastine—CYP2A6—Dexamethasone—atopic dermatitis	0.00481	0.0207	CbGbCtD
Azelastine—CYP2C9—Loratadine—atopic dermatitis	0.00478	0.0206	CbGbCtD
Azelastine—CYP2C9—Diphenhydramine—atopic dermatitis	0.00478	0.0206	CbGbCtD
Azelastine—ABCB1—Loratadine—atopic dermatitis	0.00464	0.02	CbGbCtD
Azelastine—CYP2D6—Loratadine—atopic dermatitis	0.00437	0.0188	CbGbCtD
Azelastine—CYP2D6—Diphenhydramine—atopic dermatitis	0.00437	0.0188	CbGbCtD
Azelastine—ABCB1—Methylprednisolone—atopic dermatitis	0.00424	0.0183	CbGbCtD
Azelastine—CYP1A1—Dexamethasone—atopic dermatitis	0.00411	0.0177	CbGbCtD
Azelastine—CYP3A5—Hydrocortisone—atopic dermatitis	0.00397	0.0171	CbGbCtD
Azelastine—CYP2C8—Hydrocortisone—atopic dermatitis	0.00381	0.0164	CbGbCtD
Azelastine—CYP3A4—Tacrolimus—atopic dermatitis	0.0038	0.0164	CbGbCtD
Azelastine—CYP2C19—Prednisone—atopic dermatitis	0.00319	0.0137	CbGbCtD
Azelastine—CYP2E1—Dexamethasone—atopic dermatitis	0.00317	0.0137	CbGbCtD
Azelastine—CYP2B6—Dexamethasone—atopic dermatitis	0.00313	0.0135	CbGbCtD
Azelastine—CYP3A4—Loratadine—atopic dermatitis	0.00278	0.012	CbGbCtD
Azelastine—ABCB1—Betamethasone—atopic dermatitis	0.00276	0.0119	CbGbCtD
Azelastine—ABCB1—Prednisolone—atopic dermatitis	0.00272	0.0117	CbGbCtD
Azelastine—ABCB1—Hydrocortisone—atopic dermatitis	0.00258	0.0111	CbGbCtD
Azelastine—ABCB1—Prednisone—atopic dermatitis	0.00257	0.0111	CbGbCtD
Azelastine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00254	0.011	CbGbCtD
Azelastine—CYP3A5—Dexamethasone—atopic dermatitis	0.00247	0.0106	CbGbCtD
Azelastine—CYP2C8—Dexamethasone—atopic dermatitis	0.00237	0.0102	CbGbCtD
Azelastine—CYP2C19—Dexamethasone—atopic dermatitis	0.00199	0.00857	CbGbCtD
Azelastine—CYP3A4—Triamcinolone—atopic dermatitis	0.00193	0.0083	CbGbCtD
Azelastine—CYP2C9—Dexamethasone—atopic dermatitis	0.00165	0.00712	CbGbCtD
Azelastine—CYP3A4—Betamethasone—atopic dermatitis	0.00165	0.00712	CbGbCtD
Azelastine—CYP3A4—Prednisolone—atopic dermatitis	0.00163	0.00703	CbGbCtD
Azelastine—ABCB1—Dexamethasone—atopic dermatitis	0.00161	0.00691	CbGbCtD
Azelastine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00155	0.00666	CbGbCtD
Azelastine—CYP3A4—Prednisone—atopic dermatitis	0.00154	0.00663	CbGbCtD
Azelastine—CYP2D6—Dexamethasone—atopic dermatitis	0.00151	0.00651	CbGbCtD
Azelastine—CYP3A4—Dexamethasone—atopic dermatitis	0.000962	0.00414	CbGbCtD
Azelastine—Weight increased—Methylprednisolone—atopic dermatitis	6.04e-05	0.000935	CcSEcCtD
Azelastine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	6e-05	0.000928	CcSEcCtD
Azelastine—Vomiting—Loratadine—atopic dermatitis	6e-05	0.000928	CcSEcCtD
Azelastine—Rash—Loratadine—atopic dermatitis	5.95e-05	0.00092	CcSEcCtD
Azelastine—Dermatitis—Loratadine—atopic dermatitis	5.94e-05	0.000919	CcSEcCtD
Azelastine—Headache—Loratadine—atopic dermatitis	5.91e-05	0.000914	CcSEcCtD
Azelastine—Face oedema—Prednisone—atopic dermatitis	5.88e-05	0.000908	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	5.87e-05	0.000908	CcSEcCtD
Azelastine—Asthenia—Mometasone—atopic dermatitis	5.81e-05	0.000898	CcSEcCtD
Azelastine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	5.8e-05	0.000897	CcSEcCtD
Azelastine—Paraesthesia—Tacrolimus—atopic dermatitis	5.79e-05	0.000895	CcSEcCtD
Azelastine—Conjunctivitis—Triamcinolone—atopic dermatitis	5.77e-05	0.000892	CcSEcCtD
Azelastine—Dyspnoea—Tacrolimus—atopic dermatitis	5.75e-05	0.000888	CcSEcCtD
Azelastine—Somnolence—Tacrolimus—atopic dermatitis	5.73e-05	0.000886	CcSEcCtD
Azelastine—Pruritus—Mometasone—atopic dermatitis	5.73e-05	0.000886	CcSEcCtD
Azelastine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	5.61e-05	0.000867	CcSEcCtD
Azelastine—Nausea—Loratadine—atopic dermatitis	5.6e-05	0.000867	CcSEcCtD
Azelastine—Epistaxis—Triamcinolone—atopic dermatitis	5.6e-05	0.000866	CcSEcCtD
Azelastine—Visual impairment—Prednisolone—atopic dermatitis	5.58e-05	0.000863	CcSEcCtD
Azelastine—Fatigue—Tacrolimus—atopic dermatitis	5.56e-05	0.000859	CcSEcCtD
Azelastine—Diarrhoea—Mometasone—atopic dermatitis	5.54e-05	0.000857	CcSEcCtD
Azelastine—Pain—Tacrolimus—atopic dermatitis	5.51e-05	0.000852	CcSEcCtD
Azelastine—Constipation—Tacrolimus—atopic dermatitis	5.51e-05	0.000852	CcSEcCtD
Azelastine—Weight increased—Dexamethasone—atopic dermatitis	5.5e-05	0.00085	CcSEcCtD
Azelastine—Weight increased—Betamethasone—atopic dermatitis	5.5e-05	0.00085	CcSEcCtD
Azelastine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	5.39e-05	0.000834	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Prednisone—atopic dermatitis	5.37e-05	0.00083	CcSEcCtD
Azelastine—Rash—Fluocinolone Acetonide—atopic dermatitis	5.35e-05	0.000827	CcSEcCtD
Azelastine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	5.34e-05	0.000826	CcSEcCtD
Azelastine—Rhinitis—Triamcinolone—atopic dermatitis	5.34e-05	0.000826	CcSEcCtD
Azelastine—Rhinitis—Methylprednisolone—atopic dermatitis	5.33e-05	0.000824	CcSEcCtD
Azelastine—Headache—Fluocinolone Acetonide—atopic dermatitis	5.31e-05	0.000821	CcSEcCtD
Azelastine—Feeling abnormal—Tacrolimus—atopic dermatitis	5.31e-05	0.000821	CcSEcCtD
Azelastine—Pharyngitis—Triamcinolone—atopic dermatitis	5.29e-05	0.000818	CcSEcCtD
Azelastine—Eye disorder—Hydrocortisone—atopic dermatitis	5.29e-05	0.000818	CcSEcCtD
Azelastine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	5.27e-05	0.000815	CcSEcCtD
Azelastine—Conjunctivitis—Betamethasone—atopic dermatitis	5.23e-05	0.000809	CcSEcCtD
Azelastine—Conjunctivitis—Dexamethasone—atopic dermatitis	5.23e-05	0.000809	CcSEcCtD
Azelastine—Vomiting—Mometasone—atopic dermatitis	5.15e-05	0.000796	CcSEcCtD
Azelastine—Visual impairment—Methylprednisolone—atopic dermatitis	5.12e-05	0.000792	CcSEcCtD
Azelastine—Rash—Mometasone—atopic dermatitis	5.11e-05	0.000789	CcSEcCtD
Azelastine—Dermatitis—Mometasone—atopic dermatitis	5.1e-05	0.000789	CcSEcCtD
Azelastine—Abdominal pain—Tacrolimus—atopic dermatitis	5.09e-05	0.000788	CcSEcCtD
Azelastine—Body temperature increased—Tacrolimus—atopic dermatitis	5.09e-05	0.000788	CcSEcCtD
Azelastine—Headache—Mometasone—atopic dermatitis	5.07e-05	0.000784	CcSEcCtD
Azelastine—Nausea—Fluocinolone Acetonide—atopic dermatitis	5.04e-05	0.000779	CcSEcCtD
Azelastine—Eye disorder—Methylprednisolone—atopic dermatitis	4.97e-05	0.000768	CcSEcCtD
Azelastine—Nausea—Mometasone—atopic dermatitis	4.81e-05	0.000744	CcSEcCtD
Azelastine—Weight increased—Prednisone—atopic dermatitis	4.79e-05	0.00074	CcSEcCtD
Azelastine—Vision blurred—Prednisolone—atopic dermatitis	4.75e-05	0.000735	CcSEcCtD
Azelastine—Hypersensitivity—Tacrolimus—atopic dermatitis	4.75e-05	0.000734	CcSEcCtD
Azelastine—Ill-defined disorder—Prednisolone—atopic dermatitis	4.68e-05	0.000724	CcSEcCtD
Azelastine—Visual impairment—Dexamethasone—atopic dermatitis	4.66e-05	0.00072	CcSEcCtD
Azelastine—Visual impairment—Betamethasone—atopic dermatitis	4.66e-05	0.00072	CcSEcCtD
Azelastine—Asthenia—Tacrolimus—atopic dermatitis	4.62e-05	0.000715	CcSEcCtD
Azelastine—Ill-defined disorder—Hydrocortisone—atopic dermatitis	4.57e-05	0.000707	CcSEcCtD
Azelastine—Pruritus—Tacrolimus—atopic dermatitis	4.56e-05	0.000705	CcSEcCtD
Azelastine—Malaise—Prednisolone—atopic dermatitis	4.55e-05	0.000703	CcSEcCtD
Azelastine—Dysgeusia—Triamcinolone—atopic dermatitis	4.54e-05	0.000702	CcSEcCtD
Azelastine—Vertigo—Prednisolone—atopic dermatitis	4.53e-05	0.000701	CcSEcCtD
Azelastine—Eye disorder—Dexamethasone—atopic dermatitis	4.52e-05	0.000699	CcSEcCtD
Azelastine—Eye disorder—Betamethasone—atopic dermatitis	4.52e-05	0.000699	CcSEcCtD
Azelastine—Back pain—Triamcinolone—atopic dermatitis	4.49e-05	0.000694	CcSEcCtD
Azelastine—Malaise—Hydrocortisone—atopic dermatitis	4.44e-05	0.000687	CcSEcCtD
Azelastine—Vertigo—Hydrocortisone—atopic dermatitis	4.43e-05	0.000684	CcSEcCtD
Azelastine—Diarrhoea—Tacrolimus—atopic dermatitis	4.41e-05	0.000682	CcSEcCtD
Azelastine—Hypertension—Prednisolone—atopic dermatitis	4.35e-05	0.000673	CcSEcCtD
Azelastine—Ill-defined disorder—Triamcinolone—atopic dermatitis	4.3e-05	0.000665	CcSEcCtD
Azelastine—Ill-defined disorder—Methylprednisolone—atopic dermatitis	4.29e-05	0.000664	CcSEcCtD
Azelastine—Dizziness—Tacrolimus—atopic dermatitis	4.26e-05	0.000659	CcSEcCtD
Azelastine—Hypertension—Hydrocortisone—atopic dermatitis	4.25e-05	0.000658	CcSEcCtD
Azelastine—Discomfort—Prednisolone—atopic dermatitis	4.24e-05	0.000656	CcSEcCtD
Azelastine—Myalgia—Hydrocortisone—atopic dermatitis	4.19e-05	0.000648	CcSEcCtD
Azelastine—Malaise—Triamcinolone—atopic dermatitis	4.18e-05	0.000647	CcSEcCtD
Azelastine—Anxiety—Hydrocortisone—atopic dermatitis	4.18e-05	0.000646	CcSEcCtD
Azelastine—Malaise—Methylprednisolone—atopic dermatitis	4.17e-05	0.000645	CcSEcCtD
Azelastine—Vertigo—Triamcinolone—atopic dermatitis	4.17e-05	0.000644	CcSEcCtD
Azelastine—Vertigo—Methylprednisolone—atopic dermatitis	4.16e-05	0.000643	CcSEcCtD
Azelastine—Discomfort—Hydrocortisone—atopic dermatitis	4.14e-05	0.000641	CcSEcCtD
Azelastine—Anaphylactic shock—Prednisolone—atopic dermatitis	4.12e-05	0.000636	CcSEcCtD
Azelastine—Vomiting—Tacrolimus—atopic dermatitis	4.1e-05	0.000634	CcSEcCtD
Azelastine—Rash—Tacrolimus—atopic dermatitis	4.06e-05	0.000628	CcSEcCtD
Azelastine—Dermatitis—Tacrolimus—atopic dermatitis	4.06e-05	0.000628	CcSEcCtD
Azelastine—Cough—Triamcinolone—atopic dermatitis	4.05e-05	0.000626	CcSEcCtD
Azelastine—Headache—Tacrolimus—atopic dermatitis	4.04e-05	0.000624	CcSEcCtD
Azelastine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	4.02e-05	0.000622	CcSEcCtD
Azelastine—Tachycardia—Prednisolone—atopic dermatitis	4.02e-05	0.000621	CcSEcCtD
Azelastine—Hypertension—Triamcinolone—atopic dermatitis	4e-05	0.000619	CcSEcCtD
Azelastine—Hypertension—Methylprednisolone—atopic dermatitis	4e-05	0.000618	CcSEcCtD
Azelastine—Infection—Hydrocortisone—atopic dermatitis	3.99e-05	0.000618	CcSEcCtD
Azelastine—Myalgia—Triamcinolone—atopic dermatitis	3.95e-05	0.000611	CcSEcCtD
Azelastine—Myalgia—Methylprednisolone—atopic dermatitis	3.94e-05	0.000609	CcSEcCtD
Azelastine—Eye disorder—Prednisone—atopic dermatitis	3.93e-05	0.000608	CcSEcCtD
Azelastine—Anxiety—Methylprednisolone—atopic dermatitis	3.93e-05	0.000607	CcSEcCtD
Azelastine—Tachycardia—Hydrocortisone—atopic dermatitis	3.92e-05	0.000607	CcSEcCtD
Azelastine—Flushing—Prednisone—atopic dermatitis	3.91e-05	0.000604	CcSEcCtD
Azelastine—Ill-defined disorder—Betamethasone—atopic dermatitis	3.9e-05	0.000604	CcSEcCtD
Azelastine—Ill-defined disorder—Dexamethasone—atopic dermatitis	3.9e-05	0.000604	CcSEcCtD
Azelastine—Discomfort—Triamcinolone—atopic dermatitis	3.9e-05	0.000603	CcSEcCtD
Azelastine—Discomfort—Methylprednisolone—atopic dermatitis	3.89e-05	0.000602	CcSEcCtD
Azelastine—Dry mouth—Triamcinolone—atopic dermatitis	3.86e-05	0.000597	CcSEcCtD
Azelastine—Nausea—Tacrolimus—atopic dermatitis	3.83e-05	0.000592	CcSEcCtD
Azelastine—Confusional state—Methylprednisolone—atopic dermatitis	3.81e-05	0.000589	CcSEcCtD
Azelastine—Malaise—Betamethasone—atopic dermatitis	3.8e-05	0.000587	CcSEcCtD
Azelastine—Malaise—Dexamethasone—atopic dermatitis	3.8e-05	0.000587	CcSEcCtD
Azelastine—Anaphylactic shock—Triamcinolone—atopic dermatitis	3.79e-05	0.000585	CcSEcCtD
Azelastine—Vertigo—Betamethasone—atopic dermatitis	3.78e-05	0.000585	CcSEcCtD
Azelastine—Vertigo—Dexamethasone—atopic dermatitis	3.78e-05	0.000585	CcSEcCtD
Azelastine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	3.78e-05	0.000584	CcSEcCtD
Azelastine—Infection—Triamcinolone—atopic dermatitis	3.76e-05	0.000581	CcSEcCtD
Azelastine—Infection—Methylprednisolone—atopic dermatitis	3.75e-05	0.00058	CcSEcCtD
Azelastine—Paraesthesia—Prednisolone—atopic dermatitis	3.7e-05	0.000572	CcSEcCtD
Azelastine—Tachycardia—Triamcinolone—atopic dermatitis	3.69e-05	0.000571	CcSEcCtD
Azelastine—Tachycardia—Methylprednisolone—atopic dermatitis	3.69e-05	0.00057	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	3.66e-05	0.000566	CcSEcCtD
Azelastine—Hypertension—Betamethasone—atopic dermatitis	3.63e-05	0.000562	CcSEcCtD
Azelastine—Hypertension—Dexamethasone—atopic dermatitis	3.63e-05	0.000562	CcSEcCtD
Azelastine—Paraesthesia—Hydrocortisone—atopic dermatitis	3.61e-05	0.000558	CcSEcCtD
Azelastine—Myalgia—Betamethasone—atopic dermatitis	3.58e-05	0.000554	CcSEcCtD
Azelastine—Myalgia—Dexamethasone—atopic dermatitis	3.58e-05	0.000554	CcSEcCtD
Azelastine—Anxiety—Dexamethasone—atopic dermatitis	3.57e-05	0.000552	CcSEcCtD
Azelastine—Anxiety—Betamethasone—atopic dermatitis	3.57e-05	0.000552	CcSEcCtD
Azelastine—Discomfort—Dexamethasone—atopic dermatitis	3.54e-05	0.000547	CcSEcCtD
Azelastine—Discomfort—Betamethasone—atopic dermatitis	3.54e-05	0.000547	CcSEcCtD
Azelastine—Pain—Prednisolone—atopic dermatitis	3.52e-05	0.000544	CcSEcCtD
Azelastine—Fatigue—Hydrocortisone—atopic dermatitis	3.47e-05	0.000536	CcSEcCtD
Azelastine—Vision blurred—Prednisone—atopic dermatitis	3.45e-05	0.000534	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	3.45e-05	0.000533	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	3.44e-05	0.000532	CcSEcCtD
Azelastine—Pain—Hydrocortisone—atopic dermatitis	3.44e-05	0.000532	CcSEcCtD
Azelastine—Anaphylactic shock—Betamethasone—atopic dermatitis	3.43e-05	0.000531	CcSEcCtD
Azelastine—Anaphylactic shock—Dexamethasone—atopic dermatitis	3.43e-05	0.000531	CcSEcCtD
Azelastine—Infection—Dexamethasone—atopic dermatitis	3.41e-05	0.000528	CcSEcCtD
Azelastine—Infection—Betamethasone—atopic dermatitis	3.41e-05	0.000528	CcSEcCtD
Azelastine—Ill-defined disorder—Prednisone—atopic dermatitis	3.4e-05	0.000526	CcSEcCtD
Azelastine—Paraesthesia—Triamcinolone—atopic dermatitis	3.4e-05	0.000526	CcSEcCtD
Azelastine—Feeling abnormal—Prednisolone—atopic dermatitis	3.39e-05	0.000524	CcSEcCtD
Azelastine—Paraesthesia—Methylprednisolone—atopic dermatitis	3.39e-05	0.000524	CcSEcCtD
Azelastine—Dyspnoea—Triamcinolone—atopic dermatitis	3.37e-05	0.000522	CcSEcCtD
Azelastine—Agitation—Prednisone—atopic dermatitis	3.37e-05	0.000521	CcSEcCtD
Azelastine—Tachycardia—Dexamethasone—atopic dermatitis	3.35e-05	0.000518	CcSEcCtD
Azelastine—Tachycardia—Betamethasone—atopic dermatitis	3.35e-05	0.000518	CcSEcCtD
Azelastine—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.31e-05	0.000512	CcSEcCtD
Azelastine—Malaise—Prednisone—atopic dermatitis	3.3e-05	0.000511	CcSEcCtD
Azelastine—Vertigo—Prednisone—atopic dermatitis	3.29e-05	0.000509	CcSEcCtD
Azelastine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.29e-05	0.000508	CcSEcCtD
Azelastine—Fatigue—Triamcinolone—atopic dermatitis	3.26e-05	0.000505	CcSEcCtD
Azelastine—Fatigue—Methylprednisolone—atopic dermatitis	3.26e-05	0.000504	CcSEcCtD
Azelastine—Pain—Triamcinolone—atopic dermatitis	3.24e-05	0.000501	CcSEcCtD
Azelastine—Body temperature increased—Hydrocortisone—atopic dermatitis	3.18e-05	0.000491	CcSEcCtD
Azelastine—Abdominal pain—Hydrocortisone—atopic dermatitis	3.18e-05	0.000491	CcSEcCtD
Azelastine—Hypertension—Prednisone—atopic dermatitis	3.16e-05	0.000489	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.13e-05	0.000484	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.13e-05	0.000484	CcSEcCtD
Azelastine—Myalgia—Prednisone—atopic dermatitis	3.12e-05	0.000482	CcSEcCtD
Azelastine—Feeling abnormal—Triamcinolone—atopic dermatitis	3.12e-05	0.000482	CcSEcCtD
Azelastine—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.11e-05	0.000481	CcSEcCtD
Azelastine—Anxiety—Prednisone—atopic dermatitis	3.11e-05	0.000481	CcSEcCtD
Azelastine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.09e-05	0.000478	CcSEcCtD
Azelastine—Paraesthesia—Dexamethasone—atopic dermatitis	3.08e-05	0.000477	CcSEcCtD
Azelastine—Paraesthesia—Betamethasone—atopic dermatitis	3.08e-05	0.000477	CcSEcCtD
Azelastine—Discomfort—Prednisone—atopic dermatitis	3.08e-05	0.000477	CcSEcCtD
Azelastine—Hypersensitivity—Prednisolone—atopic dermatitis	3.03e-05	0.000469	CcSEcCtD
Azelastine—Body temperature increased—Triamcinolone—atopic dermatitis	2.99e-05	0.000463	CcSEcCtD
Azelastine—Anaphylactic shock—Prednisone—atopic dermatitis	2.99e-05	0.000463	CcSEcCtD
Azelastine—Abdominal pain—Methylprednisolone—atopic dermatitis	2.99e-05	0.000462	CcSEcCtD
Azelastine—Infection—Prednisone—atopic dermatitis	2.97e-05	0.000459	CcSEcCtD
Azelastine—Hypersensitivity—Hydrocortisone—atopic dermatitis	2.96e-05	0.000458	CcSEcCtD
Azelastine—Fatigue—Dexamethasone—atopic dermatitis	2.96e-05	0.000458	CcSEcCtD
Azelastine—Fatigue—Betamethasone—atopic dermatitis	2.96e-05	0.000458	CcSEcCtD
Azelastine—Pain—Betamethasone—atopic dermatitis	2.94e-05	0.000454	CcSEcCtD
Azelastine—Pain—Dexamethasone—atopic dermatitis	2.94e-05	0.000454	CcSEcCtD
Azelastine—Tachycardia—Prednisone—atopic dermatitis	2.92e-05	0.000451	CcSEcCtD
Azelastine—Asthenia—Hydrocortisone—atopic dermatitis	2.88e-05	0.000446	CcSEcCtD
Azelastine—Pruritus—Hydrocortisone—atopic dermatitis	2.84e-05	0.00044	CcSEcCtD
Azelastine—Feeling abnormal—Dexamethasone—atopic dermatitis	2.83e-05	0.000438	CcSEcCtD
Azelastine—Feeling abnormal—Betamethasone—atopic dermatitis	2.83e-05	0.000438	CcSEcCtD
Azelastine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	2.81e-05	0.000434	CcSEcCtD
Azelastine—Gastrointestinal pain—Betamethasone—atopic dermatitis	2.81e-05	0.000434	CcSEcCtD
Azelastine—Hypersensitivity—Triamcinolone—atopic dermatitis	2.79e-05	0.000431	CcSEcCtD
Azelastine—Hypersensitivity—Methylprednisolone—atopic dermatitis	2.78e-05	0.00043	CcSEcCtD
Azelastine—Diarrhoea—Hydrocortisone—atopic dermatitis	2.75e-05	0.000425	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	2.73e-05	0.000421	CcSEcCtD
Azelastine—Dizziness—Prednisolone—atopic dermatitis	2.72e-05	0.000421	CcSEcCtD
Azelastine—Asthenia—Triamcinolone—atopic dermatitis	2.72e-05	0.00042	CcSEcCtD
Azelastine—Abdominal pain—Dexamethasone—atopic dermatitis	2.72e-05	0.00042	CcSEcCtD
Azelastine—Body temperature increased—Betamethasone—atopic dermatitis	2.72e-05	0.00042	CcSEcCtD
Azelastine—Body temperature increased—Dexamethasone—atopic dermatitis	2.72e-05	0.00042	CcSEcCtD
Azelastine—Abdominal pain—Betamethasone—atopic dermatitis	2.72e-05	0.00042	CcSEcCtD
Azelastine—Asthenia—Methylprednisolone—atopic dermatitis	2.71e-05	0.000419	CcSEcCtD
Azelastine—Paraesthesia—Prednisone—atopic dermatitis	2.69e-05	0.000415	CcSEcCtD
Azelastine—Pruritus—Triamcinolone—atopic dermatitis	2.68e-05	0.000414	CcSEcCtD
Azelastine—Pruritus—Methylprednisolone—atopic dermatitis	2.67e-05	0.000413	CcSEcCtD
Azelastine—Dizziness—Hydrocortisone—atopic dermatitis	2.66e-05	0.000411	CcSEcCtD
Azelastine—Rash—Prednisolone—atopic dermatitis	2.6e-05	0.000401	CcSEcCtD
Azelastine—Dermatitis—Prednisolone—atopic dermatitis	2.59e-05	0.000401	CcSEcCtD
Azelastine—Diarrhoea—Methylprednisolone—atopic dermatitis	2.58e-05	0.0004	CcSEcCtD
Azelastine—Fatigue—Prednisone—atopic dermatitis	2.58e-05	0.000399	CcSEcCtD
Azelastine—Headache—Prednisolone—atopic dermatitis	2.58e-05	0.000399	CcSEcCtD
Azelastine—Constipation—Prednisone—atopic dermatitis	2.56e-05	0.000396	CcSEcCtD
Azelastine—Vomiting—Hydrocortisone—atopic dermatitis	2.56e-05	0.000395	CcSEcCtD
Azelastine—Rash—Hydrocortisone—atopic dermatitis	2.53e-05	0.000392	CcSEcCtD
Azelastine—Dermatitis—Hydrocortisone—atopic dermatitis	2.53e-05	0.000392	CcSEcCtD
Azelastine—Headache—Hydrocortisone—atopic dermatitis	2.52e-05	0.000389	CcSEcCtD
Azelastine—Dizziness—Triamcinolone—atopic dermatitis	2.5e-05	0.000387	CcSEcCtD
Azelastine—Dizziness—Methylprednisolone—atopic dermatitis	2.5e-05	0.000386	CcSEcCtD
Azelastine—Feeling abnormal—Prednisone—atopic dermatitis	2.46e-05	0.000381	CcSEcCtD
Azelastine—Asthenia—Betamethasone—atopic dermatitis	2.46e-05	0.000381	CcSEcCtD
Azelastine—Asthenia—Dexamethasone—atopic dermatitis	2.46e-05	0.000381	CcSEcCtD
Azelastine—Gastrointestinal pain—Prednisone—atopic dermatitis	2.45e-05	0.000378	CcSEcCtD
Azelastine—Nausea—Prednisolone—atopic dermatitis	2.44e-05	0.000378	CcSEcCtD
Azelastine—Pruritus—Betamethasone—atopic dermatitis	2.43e-05	0.000376	CcSEcCtD
Azelastine—Pruritus—Dexamethasone—atopic dermatitis	2.43e-05	0.000376	CcSEcCtD
Azelastine—Vomiting—Triamcinolone—atopic dermatitis	2.41e-05	0.000372	CcSEcCtD
Azelastine—Vomiting—Methylprednisolone—atopic dermatitis	2.4e-05	0.000371	CcSEcCtD
Azelastine—Nausea—Hydrocortisone—atopic dermatitis	2.39e-05	0.000369	CcSEcCtD
Azelastine—Rash—Triamcinolone—atopic dermatitis	2.39e-05	0.000369	CcSEcCtD
Azelastine—Dermatitis—Triamcinolone—atopic dermatitis	2.38e-05	0.000369	CcSEcCtD
Azelastine—Rash—Methylprednisolone—atopic dermatitis	2.38e-05	0.000368	CcSEcCtD
Azelastine—Dermatitis—Methylprednisolone—atopic dermatitis	2.38e-05	0.000368	CcSEcCtD
Azelastine—Headache—Triamcinolone—atopic dermatitis	2.37e-05	0.000367	CcSEcCtD
Azelastine—Headache—Methylprednisolone—atopic dermatitis	2.37e-05	0.000366	CcSEcCtD
Azelastine—Abdominal pain—Prednisone—atopic dermatitis	2.36e-05	0.000366	CcSEcCtD
Azelastine—Body temperature increased—Prednisone—atopic dermatitis	2.36e-05	0.000366	CcSEcCtD
Azelastine—Diarrhoea—Betamethasone—atopic dermatitis	2.35e-05	0.000363	CcSEcCtD
Azelastine—Diarrhoea—Dexamethasone—atopic dermatitis	2.35e-05	0.000363	CcSEcCtD
Azelastine—Dizziness—Dexamethasone—atopic dermatitis	2.27e-05	0.000351	CcSEcCtD
Azelastine—Dizziness—Betamethasone—atopic dermatitis	2.27e-05	0.000351	CcSEcCtD
Azelastine—Nausea—Triamcinolone—atopic dermatitis	2.25e-05	0.000348	CcSEcCtD
Azelastine—Nausea—Methylprednisolone—atopic dermatitis	2.24e-05	0.000347	CcSEcCtD
Azelastine—Hypersensitivity—Prednisone—atopic dermatitis	2.2e-05	0.000341	CcSEcCtD
Azelastine—Vomiting—Dexamethasone—atopic dermatitis	2.18e-05	0.000338	CcSEcCtD
Azelastine—Vomiting—Betamethasone—atopic dermatitis	2.18e-05	0.000338	CcSEcCtD
Azelastine—Rash—Dexamethasone—atopic dermatitis	2.17e-05	0.000335	CcSEcCtD
Azelastine—Rash—Betamethasone—atopic dermatitis	2.17e-05	0.000335	CcSEcCtD
Azelastine—Dermatitis—Betamethasone—atopic dermatitis	2.16e-05	0.000335	CcSEcCtD
Azelastine—Dermatitis—Dexamethasone—atopic dermatitis	2.16e-05	0.000335	CcSEcCtD
Azelastine—Headache—Betamethasone—atopic dermatitis	2.15e-05	0.000333	CcSEcCtD
Azelastine—Headache—Dexamethasone—atopic dermatitis	2.15e-05	0.000333	CcSEcCtD
Azelastine—Asthenia—Prednisone—atopic dermatitis	2.15e-05	0.000332	CcSEcCtD
Azelastine—Pruritus—Prednisone—atopic dermatitis	2.12e-05	0.000327	CcSEcCtD
Azelastine—Diarrhoea—Prednisone—atopic dermatitis	2.05e-05	0.000316	CcSEcCtD
Azelastine—Nausea—Betamethasone—atopic dermatitis	2.04e-05	0.000315	CcSEcCtD
Azelastine—Nausea—Dexamethasone—atopic dermatitis	2.04e-05	0.000315	CcSEcCtD
Azelastine—Dizziness—Prednisone—atopic dermatitis	1.98e-05	0.000306	CcSEcCtD
Azelastine—Vomiting—Prednisone—atopic dermatitis	1.9e-05	0.000294	CcSEcCtD
Azelastine—Rash—Prednisone—atopic dermatitis	1.89e-05	0.000292	CcSEcCtD
Azelastine—Dermatitis—Prednisone—atopic dermatitis	1.88e-05	0.000291	CcSEcCtD
Azelastine—Headache—Prednisone—atopic dermatitis	1.87e-05	0.00029	CcSEcCtD
Azelastine—Nausea—Prednisone—atopic dermatitis	1.78e-05	0.000275	CcSEcCtD
Azelastine—ABCB1—Allograft Rejection—IL10—atopic dermatitis	1.95e-06	0.00332	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—CXCR3—atopic dermatitis	1.94e-06	0.00329	CbGpPWpGaD
Azelastine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	1.92e-06	0.00326	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—IL4—atopic dermatitis	1.9e-06	0.00323	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	1.88e-06	0.00319	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	1.87e-06	0.00317	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—IL5—atopic dermatitis	1.83e-06	0.00312	CbGpPWpGaD
Azelastine—KCNH2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	1.82e-06	0.00309	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CCL17—atopic dermatitis	1.81e-06	0.00307	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—NPS—atopic dermatitis	1.79e-06	0.00305	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—TAC1—atopic dermatitis	1.79e-06	0.00305	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—CXCR3—atopic dermatitis	1.76e-06	0.00299	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—CCL11—atopic dermatitis	1.75e-06	0.00298	CbGpPWpGaD
Azelastine—KCNH2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	1.74e-06	0.00296	CbGpPWpGaD
Azelastine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	1.73e-06	0.00295	CbGpPWpGaD
Azelastine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.7e-06	0.0029	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	1.7e-06	0.00289	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	1.67e-06	0.00284	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	1.67e-06	0.00284	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—IL5—atopic dermatitis	1.67e-06	0.00283	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	1.64e-06	0.00279	CbGpPWpGaD
Azelastine—CYP1A1—PPARA activates gene expression—PPARA—atopic dermatitis	1.63e-06	0.00277	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—KIF3A—atopic dermatitis	1.61e-06	0.00274	CbGpPWpGaD
Azelastine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	1.59e-06	0.00271	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—CCL11—atopic dermatitis	1.59e-06	0.0027	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—CXCL10—atopic dermatitis	1.56e-06	0.00266	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	1.52e-06	0.00258	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	1.52e-06	0.00258	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	1.49e-06	0.00253	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CMA1—atopic dermatitis	1.46e-06	0.00248	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CCL11—atopic dermatitis	1.46e-06	0.00248	CbGpPWpGaD
Azelastine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	1.43e-06	0.00244	CbGpPWpGaD
Azelastine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	1.43e-06	0.00244	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—CCR3—atopic dermatitis	1.43e-06	0.00243	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—CXCL10—atopic dermatitis	1.42e-06	0.00241	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	1.41e-06	0.0024	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCL22—atopic dermatitis	1.4e-06	0.00237	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CCL27—atopic dermatitis	1.37e-06	0.00233	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—STAT6—atopic dermatitis	1.37e-06	0.00233	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	1.35e-06	0.0023	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—CCL5—atopic dermatitis	1.35e-06	0.00229	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.35e-06	0.00229	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	1.33e-06	0.00226	CbGpPWpGaD
Azelastine—HRH3—GPCR ligand binding—CXCL8—atopic dermatitis	1.3e-06	0.00221	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—CCR3—atopic dermatitis	1.29e-06	0.0022	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—TAC1—atopic dermatitis	1.27e-06	0.00217	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—NPS—atopic dermatitis	1.27e-06	0.00217	CbGpPWpGaD
Azelastine—KCNH2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	1.27e-06	0.00215	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCL22—atopic dermatitis	1.26e-06	0.00215	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	1.26e-06	0.00214	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	1.26e-06	0.00213	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—CXCR3—atopic dermatitis	1.25e-06	0.00212	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCL27—atopic dermatitis	1.25e-06	0.00212	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CCL27—atopic dermatitis	1.24e-06	0.00211	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.23e-06	0.0021	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—CCL5—atopic dermatitis	1.22e-06	0.00208	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—CCR5—atopic dermatitis	1.21e-06	0.00206	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	1.2e-06	0.00204	CbGpPWpGaD
Azelastine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.2e-06	0.00204	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CCR3—atopic dermatitis	1.19e-06	0.00202	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—TAC1—atopic dermatitis	1.15e-06	0.00196	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—NPS—atopic dermatitis	1.15e-06	0.00196	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	1.15e-06	0.00195	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.14e-06	0.00194	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—CXCR3—atopic dermatitis	1.13e-06	0.00192	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCL27—atopic dermatitis	1.13e-06	0.00192	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCL17—atopic dermatitis	1.12e-06	0.0019	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.1e-06	0.00187	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—CCR5—atopic dermatitis	1.1e-06	0.00187	CbGpPWpGaD
Azelastine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	1.1e-06	0.00187	CbGpPWpGaD
Azelastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.09e-06	0.00185	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	1.07e-06	0.00182	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TAC1—atopic dermatitis	1.06e-06	0.0018	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—NPS—atopic dermatitis	1.06e-06	0.0018	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CXCR3—atopic dermatitis	1.04e-06	0.00176	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.03e-06	0.00176	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.03e-06	0.00175	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	1.02e-06	0.00174	CbGpPWpGaD
Azelastine—KCNH2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.02e-06	0.00174	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—IL2—atopic dermatitis	1.02e-06	0.00173	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCL17—atopic dermatitis	1.01e-06	0.00172	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—CXCL10—atopic dermatitis	1.01e-06	0.00172	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	1.01e-06	0.00172	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1e-06	0.00171	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL5—atopic dermatitis	9.84e-07	0.00167	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	9.31e-07	0.00158	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	9.15e-07	0.00155	CbGpPWpGaD
Azelastine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	9.15e-07	0.00155	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—CXCL10—atopic dermatitis	9.15e-07	0.00155	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCL11—atopic dermatitis	9e-07	0.00153	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—FCER2—atopic dermatitis	8.88e-07	0.00151	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—CCL5—atopic dermatitis	8.7e-07	0.00148	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.58e-07	0.00146	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CXCL10—atopic dermatitis	8.39e-07	0.00143	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL22—atopic dermatitis	8.25e-07	0.0014	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCL11—atopic dermatitis	8.15e-07	0.00139	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CCR3—atopic dermatitis	8.08e-07	0.00137	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GLB1—atopic dermatitis	8.05e-07	0.00137	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—FCER2—atopic dermatitis	8.04e-07	0.00137	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—CCL5—atopic dermatitis	7.87e-07	0.00134	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—CCR5—atopic dermatitis	7.84e-07	0.00133	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ADSL—atopic dermatitis	7.72e-07	0.00131	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL22—atopic dermatitis	7.47e-07	0.00127	CbGpPWpGaD
Azelastine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	7.43e-07	0.00126	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	7.39e-07	0.00126	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL27—atopic dermatitis	7.36e-07	0.00125	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCR3—atopic dermatitis	7.34e-07	0.00125	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—CXCL8—atopic dermatitis	7.34e-07	0.00125	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CCR3—atopic dermatitis	7.32e-07	0.00124	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CCL5—atopic dermatitis	7.22e-07	0.00123	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—NPS—atopic dermatitis	7.2e-07	0.00122	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—TAC1—atopic dermatitis	7.2e-07	0.00122	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—CCR5—atopic dermatitis	7.09e-07	0.00121	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CXCR3—atopic dermatitis	7.06e-07	0.0012	CbGpPWpGaD
Azelastine—HRH3—GPCR downstream signaling—IL2—atopic dermatitis	7.01e-07	0.00119	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.85e-07	0.00116	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—IL5—atopic dermatitis	6.7e-07	0.00114	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—NGF—atopic dermatitis	6.69e-07	0.00114	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	6.67e-07	0.00113	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—CXCL8—atopic dermatitis	6.66e-07	0.00113	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL27—atopic dermatitis	6.66e-07	0.00113	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCR3—atopic dermatitis	6.64e-07	0.00113	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL17—atopic dermatitis	6.6e-07	0.00112	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—TAC1—atopic dermatitis	6.54e-07	0.00111	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—NPS—atopic dermatitis	6.54e-07	0.00111	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—TAC1—atopic dermatitis	6.52e-07	0.00111	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—NPS—atopic dermatitis	6.52e-07	0.00111	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CCR5—atopic dermatitis	6.51e-07	0.00111	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GLB1—atopic dermatitis	6.49e-07	0.0011	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CXCR3—atopic dermatitis	6.41e-07	0.00109	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CXCR3—atopic dermatitis	6.39e-07	0.00109	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—IL2—atopic dermatitis	6.37e-07	0.00108	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GLB1—atopic dermatitis	6.36e-07	0.00108	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GLB1—atopic dermatitis	6.35e-07	0.00108	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ADSL—atopic dermatitis	6.23e-07	0.00106	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.22e-07	0.00106	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ADSL—atopic dermatitis	6.1e-07	0.00104	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ADSL—atopic dermatitis	6.08e-07	0.00103	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL5—atopic dermatitis	6.08e-07	0.00103	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—IL5—atopic dermatitis	6.06e-07	0.00103	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GLB1—atopic dermatitis	6e-07	0.00102	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL17—atopic dermatitis	5.97e-07	0.00102	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—TAC1—atopic dermatitis	5.92e-07	0.00101	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—NPS—atopic dermatitis	5.92e-07	0.00101	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—KIF3A—atopic dermatitis	5.88e-07	0.000999	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CXCR3—atopic dermatitis	5.81e-07	0.000987	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ADSL—atopic dermatitis	5.75e-07	0.000977	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CXCL10—atopic dermatitis	5.71e-07	0.00097	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.63e-07	0.000957	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—NFKBIA—atopic dermatitis	5.52e-07	0.000938	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL5—atopic dermatitis	5.5e-07	0.000936	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GLB1—atopic dermatitis	5.5e-07	0.000934	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KIF3A—atopic dermatitis	5.32e-07	0.000905	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL11—atopic dermatitis	5.32e-07	0.000904	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CMA1—atopic dermatitis	5.32e-07	0.000904	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ADSL—atopic dermatitis	5.27e-07	0.000896	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CXCL10—atopic dermatitis	5.18e-07	0.000881	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CXCL10—atopic dermatitis	5.17e-07	0.000878	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STAT6—atopic dermatitis	5e-07	0.00085	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CCL5—atopic dermatitis	4.91e-07	0.000835	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GLB1—atopic dermatitis	4.91e-07	0.000834	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL11—atopic dermatitis	4.81e-07	0.000818	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CMA1—atopic dermatitis	4.81e-07	0.000818	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GLB1—atopic dermatitis	4.79e-07	0.000814	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—CXCL8—atopic dermatitis	4.74e-07	0.000805	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.72e-07	0.000802	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ADSL—atopic dermatitis	4.7e-07	0.0008	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CXCL10—atopic dermatitis	4.69e-07	0.000798	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	4.64e-07	0.000788	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ADSL—atopic dermatitis	4.59e-07	0.00078	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STAT6—atopic dermatitis	4.53e-07	0.000769	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GLB1—atopic dermatitis	4.51e-07	0.000767	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GLB1—atopic dermatitis	4.47e-07	0.00076	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCL5—atopic dermatitis	4.46e-07	0.000759	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CCL5—atopic dermatitis	4.45e-07	0.000756	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CCR5—atopic dermatitis	4.43e-07	0.000753	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.37e-07	0.000743	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCR3—atopic dermatitis	4.34e-07	0.000737	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ADSL—atopic dermatitis	4.33e-07	0.000735	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ADSL—atopic dermatitis	4.29e-07	0.000729	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—CXCL8—atopic dermatitis	4.29e-07	0.000729	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.27e-07	0.000726	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCL5—atopic dermatitis	4.04e-07	0.000687	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CCR5—atopic dermatitis	4.02e-07	0.000683	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CCR5—atopic dermatitis	4.01e-07	0.000681	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.01e-07	0.000681	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CXCL8—atopic dermatitis	3.94e-07	0.000669	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCR3—atopic dermatitis	3.92e-07	0.000667	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TAC1—atopic dermatitis	3.86e-07	0.000657	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NPS—atopic dermatitis	3.86e-07	0.000657	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GLB1—atopic dermatitis	3.82e-07	0.00065	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCR3—atopic dermatitis	3.79e-07	0.000644	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL2—atopic dermatitis	3.76e-07	0.000639	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—IL6—atopic dermatitis	3.74e-07	0.000636	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.67e-07	0.000624	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ADSL—atopic dermatitis	3.67e-07	0.000623	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	3.64e-07	0.000619	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	3.59e-07	0.000611	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.58e-07	0.000608	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NPS—atopic dermatitis	3.5e-07	0.000594	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TAC1—atopic dermatitis	3.5e-07	0.000594	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—MAPK8—atopic dermatitis	3.46e-07	0.000588	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	3.43e-07	0.000583	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.32e-07	0.000564	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.26e-07	0.000554	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL5—atopic dermatitis	3.25e-07	0.000553	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	3.06e-07	0.000521	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.95e-07	0.000502	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.83e-07	0.000481	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.79e-07	0.000474	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	2.77e-07	0.000471	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	2.68e-07	0.000455	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	2.64e-07	0.000448	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PPARA—atopic dermatitis	2.61e-07	0.000444	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	2.56e-07	0.000435	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	2.44e-07	0.000415	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	2.43e-07	0.000413	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.42e-07	0.000412	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCL5—atopic dermatitis	2.39e-07	0.000406	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	2.38e-07	0.000404	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	2.32e-07	0.000395	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	2.32e-07	0.000394	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL6—atopic dermatitis	2.21e-07	0.000376	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NGF—atopic dermatitis	2.21e-07	0.000376	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	2.2e-07	0.000374	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCR5—atopic dermatitis	2.15e-07	0.000365	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PPARA—atopic dermatitis	2.11e-07	0.000358	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL2—atopic dermatitis	2.1e-07	0.000357	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PPARA—atopic dermatitis	2.06e-07	0.000351	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PPARA—atopic dermatitis	2.06e-07	0.00035	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	2.01e-07	0.000342	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PPARA—atopic dermatitis	1.95e-07	0.000331	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	1.82e-07	0.00031	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PPARA—atopic dermatitis	1.78e-07	0.000303	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PPARA—atopic dermatitis	1.59e-07	0.000271	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PPARA—atopic dermatitis	1.55e-07	0.000264	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.46e-07	0.000249	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.45e-07	0.000247	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	1.44e-07	0.000244	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	1.37e-07	0.000233	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	1.37e-07	0.000232	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	1.3e-07	0.000221	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	1.26e-07	0.000215	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL2—atopic dermatitis	1.24e-07	0.000211	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.24e-07	0.000211	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—atopic dermatitis	1.24e-07	0.00021	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	1.14e-07	0.000194	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PPARA—atopic dermatitis	9.58e-08	0.000163	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	8.07e-08	0.000137	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—atopic dermatitis	7.3e-08	0.000124	CbGpPWpGaD
